E6007

· Eisai Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for E6007, covering 2014-07-11 to 2019-10-04. Get the full timeline:

Most recent: Clinical Trial Update: Study of E6007 in Japanese Patients With Moderate Active Ulcerative Colitis [Phase 2]